AlgoDx develops machine learning-based clinical decision support software for intensive care, utilizing predictive analytics to assess current patient conditions and forecast future health outcomes. This technology aims to enhance patient care and reduce healthcare costs by providing actionable insights for critical medical decisions.
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Intensive care units (ICUs) face challenges in making timely and accurate decisions due to the complexity of patient conditions and the volume of data generated. Clinicians need tools to synthesize real-time information and predict potential health outcomes to optimize treatment strategies.
Solution
AlgoDx provides a machine learning-based clinical decision support system designed for precision medicine in intensive care. The platform analyzes patient data to assess current conditions, forecast future health trajectories, and suggest interventions to improve outcomes. By leveraging predictive analytics, AlgoDx aims to provide actionable insights that enable clinicians to make data-driven decisions, enhance patient care, and reduce healthcare costs. The software addresses fundamental medical questions regarding a patient's present state, near-future outlook, and potential interventions for improved outcomes.
Target Audience
The primary target audience includes healthcare providers and hospitals, specifically those operating in intensive care and critical care environments.
Features
- Predictive analytics for forecasting patient health outcomes in intensive care settings
- Machine learning models trained on clinical data to identify patterns and predict risks
- Real-time assessment of patient conditions using available data streams
- Integration with existing hospital systems for seamless data flow
- FDA-cleared sepsis detection software